Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 109 Lymphoma, T-Cell, Cutaneous 27 Mycosis Fungoides 22 Skin Neoplasms 20 Sezary Syndrome 19 Lymphoma, Non-Hodgkin 16 Lymphoma, Follicular 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Neoplasm Metastasis 13 Lymphoma, Mantle-Cell 13 Lymphoma, Large-Cell, Immunoblastic 13 Lymphoma, Large-Cell, Anaplastic 13 Lymphoma, Large B-Cell, Diffuse 13 Lymphoma, B-Cell, Marginal Zone 13 Lymphoma 13 Leukemia, Lymphocytic, Chronic, B-Cell 13 Burkitt Lymphoma 13 Hodgkin Disease 12 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11 Immunoblastic Lymphadenopathy 11 Waldenstrom Macroglobulinemia 10 Keratosis, Actinic 10 Breast Neoplasms 10 Uveal Melanoma 9 Lymphoma, Extranodal NK-T-Cell 9 Leukemia, Myeloid, Acute 9 Leukemia, Hairy Cell 9 Intraocular Lymphoma 9 Carcinoma, Basal Cell 9 Neoplasms 8

Interventions

Tomography, Optical Coherence 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Mixed Tumor, Malignant × Dermatologic × Clear all

NCT02851693 2019-04-04

OCTSKIN

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Withdrawn

Carcinoma, Keratosis, Mixed Tumor, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡